First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT04067336 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04067336
Sponsor: Kura Oncology, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Neoplasm Acute Myeloid Leukemia Mixed Lineage Leukemia Mixed Lineage Acute Leukemia Acute Leukemia of Ambiguous Lineage Mixed Phenotype Acute Leukemia Acute Lymphoblastic Leukemia

Start date: 2019-09-12
Primary completion: 2028-10-16
Enrollment: 263

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.